ASCO 2014 | Science & Society
This year, ASCO, the American Society of Clinical Oncology organizes its 50th Annual Meeting, to be held May 30-June 3, 2014, in Chicago. As part of this meeting ASCO will be looking at the ‘State of Cancer’ and what has been accomplished in the last 50 years. ASCO members from around the world have been asked to share what they think is the most significant and exciting accomplishment in the ‘war against cancer’ in the first 50 years. Furthermore, during the annual meeting, there will be a lot of reflection- discussing the progress that has been made and how future progress may be guided by the success of unique milestones reached.
...Progress requires even greater long-term investment and even more societal support and vision…
2014 ASCO Theme
The theme of this year’s annual meeting is “Science & Society: The Next 50 Years.” Prospective attendees can expect to receive cutting-edge scientific presentations, information and comprehensive educational content. In addition to ‘learning’ about cancer, ASCO attendees will have the opportunity to debate, and discuss exciting and practice changing advances in oncology.
Commenting on the planned program, 2013-2014 ASCO President Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center said: “Throughout ASCO’s first 50 years, we have collaboratively made life-prolonging and life-saving advances across all areas of oncology. At the 2014 Annual Meeting, we will hear clinical and scientific results that promise to broaden and accelerate global progress against cancer.”
This years theme focuses on opportunities for the community of clinicians and researchers to lead all of society in the quest for knowledge and insight. It highlights the unique role that clinicians involved in the management and care of patients with cancer can play in closing knowledge gaps that can develop between those who work in science and those who govern and lead society. With the increasing depth of scientific understanding and the growing number of effective therapeutic options, there will be a growing need to communicate clinically important advances with precision and to convey the benefits of societal investment in science & medicine.
“The problem of malignancy has never been better understood than today, and the number of well organized trials to test the rational of interventions that capitalize on our growing understanding has never been greater,” Hudis noted. “But progress requires even greater long-term investment and even more societal support and vision. To accomplish this, we must continue to educate all of society, and I believe the oncology community has a rare opportunity to do this with passion.”
Reports from ASCO
Onco’Zine – The International Oncology Network, offers readers a brief selection and summary of the sessions from the 2014 ASCO Annual Meeting which feature the latest cancer research in the areas of basic and clinical science. This year, the program offered attendees the most cutting-edge science and education designed to help them to achieve the highest standard of patient care.
For more information:
- ASCO 2013 – Building Bridges to Conquer Cancer [Overview]
- ASCO 2014 – Science & Society: The Next 50 Years [Overview]
Copyright © 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.
CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematologic malignancies…is CAR-T therapy what we’ve been waiting for? Join 18+ thought-leaders...